The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Open accessAbstract
The inflammatory nature of atherosclerosis is well established but the agent(s) that incite inflammation in the artery wall remain largely unknown. Germ-free animals are susceptible to atherosclerosis, suggesting that endogenous substances initiate the inflammation. Mature atherosclerotic lesions contain macroscopic deposits of cholesterol crystals in the necrotic core, but their appearance late in atherogenesis had been thought to disqualify them as primary inflammatory stimuli. However, using a new microscopic technique, we revealed that minute cholesterol crystals are present in early diet-induced atherosclerotic lesions and that their appearance in mice coincides with the first appearance of inflammatory cells. Other crystalline substances can induce inflammation by stimulating the caspase-1-activating NLRP3 (NALP3 or cryopyrin) inflammasome, which results in cleavage and secretion of interleukin (IL)-1 family cytokines. Here we show that cholesterol crystals activate the NLRP3 inflammasome in phagocytes in vitro in a process that involves phagolysosomal damage. Similarly, when injected intraperitoneally, cholesterol crystals induce acute inflammation, which is impaired in mice deficient in components of the NLRP3 inflammasome, cathepsin B, cathepsin L or IL-1 molecules. Moreover, when mice deficient in low-density lipoprotein receptor (LDLR) were bone-marrow transplanted with NLRP3-deficient, ASC (also known as PYCARD)-deficient or IL-1alpha/beta-deficient bone marrow and fed on a high-cholesterol diet, they had markedly decreased early atherosclerosis and inflammasome-dependent IL-18 levels. Minimally modified LDL can lead to cholesterol crystallization concomitant with NLRP3 inflammasome priming and activation in macrophages. Although there is the possibility that oxidized LDL activates the NLRP3 inflammasome in vivo, our results demonstrate that crystalline cholesterol acts as an endogenous danger signal and its deposition in arteries or elsewhere is an early cause rather than a late consequence of inflammation. These findings provide new insights into the pathogenesis of atherosclerosis and indicate new potential molecular targets for the therapy of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Oxidized low-density lipoprotein (LDsL), a cholesterol carrier, can also form crystals within lysosomes after internalization [74].”
From HIV-TAT dysregulates microglial lipid metabolism through SREBP2/miR-124 axis: Implication of lipid droplet accumulation microglia in NeuroHIV (2025) · cites this paper as [74]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Elevation of CEs and BMPs was also observed in LOAD patients’ EC, suggesting disease relevance.43”
From Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist (2024) · cites this paper as [44]
Experimental — accuracy not yet measuredIn the citing paper
“Oxidized low‐density lipoprotein and cholesterol crystals activate the inflammasome, thereby leading to the processing and secretion of the proinflammatory cytokines IL‐1β and IL‐18 and ultimately triggering vascular inflammation via upregulation of adhesion molecules.9, 10”
From Trimethylamine‐N‐Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3‐SOD2‐mtROS Signaling Pathway (2017) · cites this paper as [10]
In the citing paper
“AS is decreased in several rodent models lacking NLRP3 or IL‐1 molecules, whereas in contrast, mice deficient in the IL‐1 receptor antagonist show increased AS.10”
From Trimethylamine‐N‐Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3‐SOD2‐mtROS Signaling Pathway (2017) · cites this paper as [10]
In the citing paper
“These results clearly indicate that the NLRP3 inflammasome plays a key role in the pathogenesis of vascular inflammation, thereby contributing to AS development.”
From Trimethylamine‐N‐Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3‐SOD2‐mtROS Signaling Pathway (2017) · cites this paper as [10]
In the citing paper
“Inhalation of crystalline silica can induce inflammation by stimulating the NLRP3 inflammasome, a cytosolic receptor complex that plays a critical role in driving inflammatory immune responses.”
From Volcanic Ash Activates the NLRP3 Inflammasome in Murine and Human Macrophages (2018) · cites this paper as [20]
In the citing paper
“The NLRP3 inflammasome senses crystalline danger signals that can occur during autoinflammatory diseases, such as gout or atherosclerosis, and environmental diseases, such as silicosis or asbestosis (18, 20, 22).”
From Volcanic Ash Activates the NLRP3 Inflammasome in Murine and Human Macrophages (2018) · cites this paper as [20]
In the citing paper
“inflammasome-dependent cytokine synthesis and release is a two-step process that is initiated after ligation of TLRs and other receptors capable of binding DAMPS and/or MAMPs leading to NLRP3 gene transcription, translation, and protein production (Duewell et al, 2010).”
From Danger Signals and Inflammasomes: Stress-Evoked Sterile Inflammation in Mood Disorders (2017) · cites this paper as Duewell et al, 2010
In the citing paper
“Urate and cholesterol crystals, as well as sterile particulates, for example, can bypass the requirement for ATP and P2RX7 for IL-1β production55,59.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [59]
In the citing paper
“For these sterile particulates to activate NLRP3, they must be internalized, as blockade of endocytosis by the actin-depolymerizing drug cytochalasin D inhibited NLRP3-dependent IL-1β production58,59.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [59]
In the citing paper
“Low-density lipoprotein (LDL) receptor-deficient mice, which are prone to developing atherosclerotic lesions, had lower IL-1β levels, smaller atherosclerotic lesions and less neutrophilic infiltration than wild-type mice when lethally irradiated and infused with NLRP3-deficient bone marrow59.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [59]
In the citing paper
“Lysosomal damage can occur during cellular injury and necrosis, and has also been associated with other sterile activators of NLRP3, such as cholesterol59 and silica crystals44.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [59]
In the citing paper
“However, cathepsin b-deficient macrophages have no impairment in IL-1β production in response to certain NLRP3 agonists, including LPS plus ATP, or MSU crystals, despite the impairment in their response to silica44,56,59,67.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [59]
In the citing paper
“Furthermore, there is only partial inhibition of the neutrophil infiltration and IL-1β production associated with sterile inflammation in response to cholesterol crystals44,56,59,67.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [59]
In the citing paper
“evidence to support this are the observations that artificial lysosomal rupture alone can activate NLRP3 and that pharmacological inhibition or genetic depletion of cathepsin b results in inhibition of caspase 1 activation, although this inhibition was only partial44,56,59.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S. K., Insull, W., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1995) · Circulation · doi:10.1161/01.cir.92.5.1355 · Cited by 3,506
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
Bauernfeind, F. G., Horvath, G. L., Stutz, A., Alnemri, E. S., MacDonald, K. L., Speert, D. P., Fernandes‐Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 3,087
Self-citationHornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Self-citationInnate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., & Fitzgerald, K. A. (2009) · Nature · doi:10.1038/nature07725 · Cited by 2,627
Self-citationThe NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
Self-citationThe Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Flagged first, then by citations
1 of the 31 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 501–600 of 1,023
Sokołowska, M., Chen, L., Liu, Y., Martínez‐Antón, A., Qi, H., Logun, C., Alsaaty, S., Park, Y. H., Kastner, D. L., Chae, J. J., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401343 · Cited by 177
Cell Death, Damage-Associated Molecular Patterns, and Sterile Inflammation in Cardiovascular Disease
Zheng, Y., Gardner, S. E., & Clarke, M. C. H. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.224907 · Cited by 172
Pentraxin 3 in Cardiovascular Disease
Ristagno, G., Fumagalli, F., Bottazzi, B., Mantovani, A., Olivari, D., Novelli, D., & Latini, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00823 · Cited by 170
Inflammation as a Therapeutic Target in Atherosclerosis
Nguyen, M. T., Fernando, S., Schwarz, N., Tan, J. T. M., Bursill, C. A., & Psaltis, P. J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081109 · Cited by 176
“OxLDL and other types of crystals, including uric acid crystals as seen in gout, are also known to activate the pro-inflammatory NLRP3 response [93,95].”
BackgroundThe Biological Role of Inflammation in Atherosclerosis
Wong, B. W., Meredith, A., Lin, D., & McManus, B. M. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.06.023 · Cited by 168
Microdomains, Inflammation, and Atherosclerosis
Sorci-Thomas, M. G., & Thomas, M. J. (2016) · Circulation Research · doi:10.1161/circresaha.115.306246 · Cited by 165
The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications
Herder, C., Dalmas, É., Böni‐Schnetzler, M., & Donath, M. Y. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.08.001 · Cited by 176
Unsaturated fatty acids prevent activation of NLRP3 inflammasome in human monocytes/macrophages
L’homme, L., Esser, N., Riva, L., Scheen, A. J., Paquot, N., Piette, J. G., & Legrand-Poels, S. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m037861 · Cited by 176
Fernandes, R., Viana, S., Nunes, S., & Reis, F. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.032 · Cited by 171
Targeting the Inflammasome in Cardiovascular Disease
Olsen, M. B., Gregersen, I., Sandanger, Ø., Yang, K., Sokolova, M., Halvorsen, B. L., Gullestad, L. L., Broch, K., Aukrust, P., & Louwe, M. C. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.08.006 · Cited by 178
“Notably, these crystals were colocalized with NLRP3 inflammasomes and promoted the release of IL-1b (30).”
BackgroundShared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease
Weber, B., Giles, J. T., & Liao, K. P. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-00969-7 · Cited by 185
Cigarette Smoking and Atherosclerotic Cardiovascular Disease
Ishida, M., Sakai, C., Kobayashi, Y., & Ishida, T. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv22015 · Cited by 212
The gut-liver axis in sepsis: interaction mechanisms and therapeutic potential
Zhang, X., Liu, H., Hashimoto, K., Yuan, S., & Zhang, J. (2022) · Critical Care · doi:10.1186/s13054-022-04090-1 · Cited by 200
Inflammasomes link vascular disease with neuroinflammation and brain disorders
Lénárt, N., Brough, D., & Dénes, Á. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16662043 · Cited by 170
The Role of the Immune System Beyond the Fight Against Infection
Sattler, S. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-57613-8_1 · Cited by 184
Interleukin-1 and acute brain injury
Murray, K. N., Parry‐Jones, A., & Allan, S. M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00018 · Cited by 169
Che, H., Wang, Y., Li, H., Li, Y., Sahil, A., Lv, J., Liu, Y., Yang, Z., Dong, R., Xue, H., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902692r · Cited by 166
Cadmium induces NLRP3 inflammasome-dependent pyroptosis in vascular endothelial cells
Chen, H., Lu, Y., Cao, Z., Ma, Q., Pi, H., Fang, Y., Yu, Z., Hu, H., & Zhou, Z. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.01.014 · Cited by 165
Targeting inflammation to reduce cardiovascular disease risk: A realistic clinical prospect?
Welsh, P., Grassia, G., Botha, S., Sattar, N., & Maffia, P. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13818 · Cited by 164
The immune system's involvement in obesity-driven type 2 diabetes
Shu, C. J., Benoist, C. O., & Mathis, D. J. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.12.001 · Cited by 170
Potential of anti-inflammatory agents for treatment of atherosclerosis
Chistiakov, D. A., Melnichenko, A. А., Grechko, A. V., Myasoedova, V. A., & Orekhov, A. N. (2018) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2018.01.008 · Cited by 169
Cytokine Circuits in Cardiovascular Disease
Williams, J. W., Huang, L.-H., & Randolph, G. J. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.007 · Cited by 168
Macrophages in vascular inflammation and atherosclerosis
Cochain, C., & Zernecke, A. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1941-y · Cited by 168
Macrophage Plasticity and Atherosclerosis Therapy
Lin, P. C., Ji, H., Li, Y., & Guo, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.679797 · Cited by 171
Autophagy, Pyroptosis, and Ferroptosis: New Regulatory Mechanisms for Atherosclerosis
Lin, L., Zhang, M.-X., Zhang, L., Zhang, D., Li, C., & Li, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.809955 · Cited by 166
“When the LDLR mice were transplanted with NLRP3-deficient, ASC-deficient, or IL1α/β-deficient bone marrow and fed a high cholesterol diet, they had significantly reduced early atherosclerosis and inflammasome-dependent IL-18 levels (Duewell et al., 2010), suggesting that the deficiency of the NLRP3 inflammasome signif…”
BackgroundInfluentialThe Nrf2-HO-1 system and inflammaging
O’Rourke, S. A., Shanley, L. C., & Dunne, A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1457010 · Cited by 177
Adipose Organ Development and Remodeling
Cinti, S. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170042 · Cited by 197
Role of lysosome rupture in controlling Nlrp3 signaling and necrotic cell death
Lima, H., Jacobson, L. S., Goldberg, M. F., Chandran, K., Diaz‐Griffero, F., Lisanti, M. P., & Brojatsch, J. (2013) · Cell Cycle · doi:10.4161/cc.24903 · Cited by 164
Free radicals and male reproduction.
Agarwal, A. K., & Allamaneni, S. S. R. (2011) · PubMed · Cited by 154
Liu, Z., Ma, X., Ilyas, I., Zheng, X., Luo, S., Little, P. J., Kamato, D., Sahebkar, A., Wu, W., Weng, J., et al. (2021) · Theranostics · doi:10.7150/thno.54498 · Cited by 155
High wall shear stress and high-risk plaque: an emerging concept
Eshtehardi, P., Brown, A. J., Bhargava, A., Costopoulos, C., Hung, O. Y., Corban, M., Hosseini, H., Gogas, B. D., Giddens, D. P., & Samady, H. (2017) · International journal of cardiac imaging · doi:10.1007/s10554-016-1055-1 · Cited by 162
Nasoohi, S., Ismael, S., & Ishrat, T. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0917-z · Cited by 162
Activation of immune signals during organ transplantation
Li, Q., & Lan, P. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01377-9 · Cited by 175
Litvinchuk, A., Suh, J. H., Guo, J. L., Lin, K., Davis, S. S., Bien-Ly, N., Tycksen, E., Tabor, G. T., Remolina Serrano, J., Manis, M., et al. (2024) · Neuron · doi:10.1016/j.neuron.2023.10.023 · Cited by 161
Fang, R., Tsuchiya, K., Kawamura, I., Shen, Y., Hara, H., Sakai, S., Yamamoto, T., Fernandes‐Alnemri, T., Yang, R., Hernández-Cuellar, E., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100381 · Cited by 166
The Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors
Virgilio, F. D. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006171 · Cited by 168
“It has been reported that cholesterol crystals destabilize the phagosomes and cause inflammasome activation (Duewell et al., 2010).”
BackgroundGan, W., Ren, J., Li, T., Lv, S., Li, C., Liu, Z., & Yang, M. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.001 · Cited by 160
Autophagy limits activation of the inflammasomes
Takahama, M., Akira, S., & Saitoh, T. (2017) · Immunological Reviews · doi:10.1111/imr.12613 · Cited by 163
The Inflammasome in Myocardial Injury and Cardiac Remodeling
Toldo, S. A., Mezzaroma, E., Mauro, A. G., Salloum, F. N., Tassell, B. W. V., & Abbate, A. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5989 · Cited by 165
Robertson, S. E. J., Martínez, G. J., Payet, C. A., Barraclough, J., Celermajer, D. S., Bursill, C. A., & Patel, S. (2016) · Clinical Science · doi:10.1042/cs20160090 · Cited by 170
Mitochondrial DNA as an inflammatory mediator in cardiovascular diseases
Nakayama, H., & Otsu, K. (2018) · Biochemical Journal · doi:10.1042/bcj20170714 · Cited by 160
NLRP3 inflammasome activation in inflammaging
Latz, E., & Duewell, P. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.001 · Cited by 174
Self-citationFoam Cells: One Size Doesn’t Fit All
Guerrini, V., & Gennaro, M. L. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.10.002 · Cited by 164
Meng, Q., Li, Y., Ji, T., Chao, Y., Li, J., Fu, Y., Wang, S., Chen, Q., Chen, W., Huang, F., et al. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2020.08.010 · Cited by 159
“NLRP3 inflammasome induced endothelial cell pyroptosis accompanied by aortic atherosclerosis was shown to be aggravated in mice with hyperlipidemia [15,18,19].”
BackgroundRetractedThe role of T and B cells in human atherosclerosis and atherothrombosis
Ammirati, E., Moroni, F., Magnoni, M., & Camici, P. G. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12477 · Cited by 160
Spectrum and Mechanisms of Inflammasome Activation by Chitosan
Bueter, C. L., Lee, C. K., Wang, J. P., Ostroff, G. R., Specht, C. A., & Levitz, S. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301695 · Cited by 161
Lee, J. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0023-8 · Cited by 161
Zhang, H., Chen, X., Zong, B., Yuan, H., Wang, Z., Wei, Y., Wang, X., Liu, G., Zhang, J., Li, S., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13743 · Cited by 158
Targeting the Immune System in Atherosclerosis
Zhao, T. X., & Mallat, Z. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.12.083 · Cited by 161
Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach
Nigrovic, P. A., Lee, P. Y., & Hoffman, H. M. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.08.017 · Cited by 162
Luo, H., Mu, W.-C., Karki, R., Chiang, H.-H., Mohrin, M., Shin, J. J., Ohkubo, R., Ito, K., Kanneganti, T.-D., & Chen, D. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.101 · Cited by 161
“…inflammation in sterile inflammatory diseases associated with aging, such as Alzheimer’s disease, Parkinson’s disease, obesity, diabetes, multiple sclerosis, and cancer (Duewell et al., 2010; Guo et al., 2015; Heneka et al., 2013; Inoue et al., 2012; Jourdan et al., 2013; Yan et al., 2015).”
Karasawa, T., Kawashima, A., Usui-Kawanishi, F., Watanabe, S., Kimura, H., Kamata, R., Shirasuna, K., Koyama, Y., Sato-Tomita, A., Matsuzaka, T., et al. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.310581 · Cited by 162
Yuan, X., Wang, L., Bhat, O. M., Lohner, H., & Li, P. (2018) · Redox Biology · doi:10.1016/j.redox.2018.02.007 · Cited by 162
“atherosclerosis induced by high cholesterol was ameliorated [54].”
BackgroundKimura, Y., Yanagida, T., Onda, A., Tsukui, D., Hosoyamada, M., & Kono, H. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313224 · Cited by 156
Self-citationJäger, E., Murthy, S., Schmidt, C., Hahn, M., Strobel, S., Peters, A., Stäubert, C., Sungur, P., Venus, T., Geisler, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17749-6 · Cited by 157
Kahlenberg, J. M., & Kaplan, M. J. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000088 · Cited by 156
Newby, A. C. (2016) · Experimental Physiology · doi:10.1113/ep085567 · Cited by 159
“The potential mediators of MMP overproduction include IL-1β, which can be produced in plaques in response to oxidised LDL (Williams & Tabas, 1995) and as a result of inflammasome activation by cholesterol crystals (Duewell et al. , 2010; Rajamaki et al. , 2010).”
Kong, F., Ye, B., Cao, J., Cai, X., Lü, L., Huang, S., Huang, W., & Huang, Z. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00369 · Cited by 162
“Moreover, cholesterol crystals induce NLRP3 inflammasome activation and IL-1β secretion in human macrophages (Duewell et al., 2010; Rajamaki et al., 2010).”
BackgroundChen, B., Li, H., Ou, G., Ren, L., Yang, X., & Zeng, M. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1974-z · Cited by 159
Mechanistic Insights into the Link between Gut Dysbiosis and Major Depression: An Extensive Review
Sonali, S., Ray, B., Hediyal, T. A., Rathipriya, A. G., Sunanda, T., Mahalakshmi, A. M., Rungratanawanich, W., Essa, M. M., Qoronfleh, M. W., Chidambaram, S. B., et al. (2022) · Cells · doi:10.3390/cells11081362 · Cited by 166
“, interleukin (IL)-18, IL-1, IL-6, and TNF-α) and peptidoglycan metabolites [64,65].”
BackgroundPhenotypic modulation of macrophages in response to plaque lipids
Adamson, S., & Leitinger, N. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834a97e4 · Cited by 154
Role of inflammasomes in the pathogenesis of periodontal disease and therapeutics
Marchesan, J. T., Girnary, M., MOSS, K. L., Monaghan, E., Egnatz, G. J., Jiao, Y., Zhang, S., Beck, J., & Swanson, K. V. (2019) · Periodontology 2000 · doi:10.1111/prd.12269 · Cited by 167
Periodontal therapy and cardiovascular risk
Orlandi, M., Graziani, F., & D'Aiuto, F. (2020) · Periodontology 2000 · doi:10.1111/prd.12299 · Cited by 155
Bauer, C. A., Duewell, P., Lehr, H., Endres, S., & Schnurr, M. M. (2012) · Digestive Diseases · doi:10.1159/000341681 · Cited by 152
Self-citationSuhalim, J. L., Chung, C., Lilledahl, M. B., Lim, R. S., Levi, M., Tromberg, B. J., & Potma, E. O. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.03.016 · Cited by 157
Curcumin suppresses NLRP3 inflammasome activation and protects against LPS‐induced septic shock
Gong, Z., Zhou, J., Li, H., Gao, Y., Xu, C., Zhao, S., Chen, Y., Cai, W., & Wu, J. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500316 · Cited by 154
The role of inflammasome-derived IL-1 in driving IL-17 responses
Mills, K. H. G., Dungan, L. S., Jones, S. A., & Harris, J. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1012543 · Cited by 159
Inflammasome activation in multiple sclerosis and experimental autoimmune encephalomyelitis ( EAE )
Barclay, W., & Shinohara, M. L. (2016) · Brain Pathology · doi:10.1111/bpa.12477 · Cited by 154
“Involvement of the NLRP3 inflammasome in sterile inflammation is found in diseases such as gout, atherosclerosis, the cryopyrin-associated periodic syndromes (CAPS), and Alzheimer’s disease (6, 20, 33, 71).”
Strategies for Targeting the NLRP3 Inflammasome in the Clinical and Preclinical Space
Schwaid, A. G., & Spencer, K. B. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01307 · Cited by 154
Innate immunity and monocyte-macrophage activation in atherosclerosis
Shalhoub, J., Falck-Hansen, M., Davies, A. H., & Monaco, C. G. (2011) · Journal of Inflammation · doi:10.1186/1476-9255-8-9 · Cited by 160
Impact of Gut Microbiota and Diet on the Development of Atherosclerosis in Apoe −/− Mice
Jonsson, A. L., Caesar, R., Akrami, R., Reinhardt, C., Hållenius, F. F., Borén, J., & Bäckhed, F. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311233 · Cited by 157
“cholesterol crystals may form sterile inflammation by activating inflammasomes.(41)”
BackgroundRole of Nrf2 in the pathogenesis of atherosclerosis
Mimura, J., & Itoh, K. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.019 · Cited by 156
Steinberg, G. R., & Schertzer, J. D. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.11 · Cited by 150
Abais, J. M., Xia, M., Li, G., Chen, Y., Conley, S. M., Gehr, T. W. B., Boini, K. M., & Li, P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.567537 · Cited by 153
Libby, P. (2021) · Cells · doi:10.3390/cells10040951 · Cited by 158
Addressing dyslipidemic risk beyond LDL-cholesterol
Tall, A. R., Thomas, D. G., Gonzalez-Cabodevilla, A. G., & Goldberg, I. J. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148559 · Cited by 150
“However, excessive cholesterol loading that is not compensated by cholesterol esterification or cholesterol efflux may lead to ER stress and cell death (71), as well as to activation of the NLRP3 inflammasome and formation of neutrophil extracellular traps (72, 73), contributing to the formation of unstable plaques, p…”
BackgroundA2E Induces IL-1ß Production in Retinal Pigment Epithelial Cells via the NLRP3 Inflammasome
Anderson, O. A., Finkelstein, A., & Shima, D. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067263 · Cited by 152
Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis
Gong, Z., Zhou, J., Zhao, S., Tian, C., Wang, P., Xu, C., Chen, Y., Cai, W., & Wu, J. S. (2016) · Oncotarget · doi:10.18632/oncotarget.13796 · Cited by 149
Li, X., Thome, S., Ma, X., Amrute‐Nayak, M., Finigan, A. J., Kitt, L., Masters, L. M., James, J. R., Shi, Y., Meng, G., et al. (2017) · Nature Communications · doi:10.1038/ncomms15986 · Cited by 160
Immunobiology of Atherosclerosis: A Complex Net of Interactions
Herrero‐Fernández, B., Gómez-Bris, R., Somovilla-Crespo, B., & González, J. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215293 · Cited by 158
Defective autophagy in atherosclerosis: to die or to senesce?
Grootaert, M. O. J., Roth, L., Schrijvers, D. M., De Meyer, G. R. Y., & Martinet, W. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7687083 · Cited by 147
NLRP3 inflammasome: a promising target in ischemic stroke
Gao, L., Dong, Q., Song, Z., Shen, F., Shi, J., & Li, Y. (2016) · Inflammation Research · doi:10.1007/s00011-016-0981-7 · Cited by 150
Ancillary Activity: Beyond Core Metabolism in Immune Cells
Puleston, D. J., Villa, M., & Pearce, E. L. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.019 · Cited by 150
“Of note, cholesterol crystals found in atherosclerotic lesions and scavenged by macrophages activate the inflammasome and may underlie the ability of macrophages to affect the inflammatory response in atherosclerosis (Duewell et al., 2010).”
BackgroundNovel Insights Into the NLRP3 Inflammasome in Atherosclerosis
Jin, Y. H., & Fu, J. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012219 · Cited by 153
“NLRP3 can sense various types of the metabolic stress molecules, as exemplified by cholesterol crystals (CCs)(9) and oxLDL.(9,36) We will discuss how CCs and oxLDL drive atherosclerosis later.”
BackgroundResultInfluentialGoldbach‐Mansky, R. T. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04533.x · Cited by 148
Nov, O., Shapiro, H., Ovadia, H., Tarnovscki, T., Dvir, I., Shemesh, E., Kovsan, J., Shelef, I., Carmi, Y., Voronov, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053626 · Cited by 147
Bailey‐Downs, L. C., Tucsek, Z., Toth, P. P., Sosnowska, D., Gautam, T., Sonntag, W. E., Csiszár, A., & Ungvari, Z. I. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls238 · Cited by 146
Zheng, F. Y., Xing, S., Gong, Z., Mu, W., & Xing, Q. (2014) · Mediators of Inflammation · doi:10.1155/2014/507208 · Cited by 147
AMP-Activated Protein Kinase Regulation of the NLRP3 Inflammasome during Aging
Cordero, M. D., Williams, M. R., & Ryffel, B. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.10.009 · Cited by 149
The physiology of foamy phagocytes in multiple sclerosis
Grajchen, E., Hendriks, J. J. A., & Bogie, J. F. J. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0628-8 · Cited by 160
Zhang, T., Yan, Z., Zheng, X., Wang, S., Fan, J., & Liu, Z. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.02.046 · Cited by 146
Dai, X., Liao, R., Liu, C., Liu, S., Huang, H., Liu, J., Jin, T., Guo, H., Zheng, Z., Xia, M., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102033 · Cited by 147
Inflammatory Caspases: Toward a Unified Model for Caspase Activation by Inflammasomes
Ross, C. M., Chan, A. H., von Pein, J. B., Maddugoda, M. P., Boucher, D., & Schroder, K. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101220-030653 · Cited by 157
Structural basis for the oligomerization-mediated regulation of NLRP3 inflammasome activation
Ohto, U., Kamitsukasa, Y., Ishida, H., Zhang, Z., Murakami, K., Hirama, C., Maekawa, S., & Shimizu, T. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121353119 · Cited by 152
Mulay, S. R., & Anders, H. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1601611 · Cited by 154
Innate immunity as a target for acute cardioprotection
Zuurbier, C. J., Abbate, A., Cabrera-Fuentes, H. A., Cohen, M. V., Collino, M., de Kleijn, D. P. V., Downey, J. M., Pagliaro, P., Preissner, K. T., Takahashi, M., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy304 · Cited by 149
Zhang, X., Xu, A., Lv, J., Zhang, Q., Ran, Y., Wei, C., & Wu, J. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111822 · Cited by 148
Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review
Zhang, F.-S., He, Q.-Z., Qin, C. X., Little, P. J., Weng, J., & Xu, S. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00835-w · Cited by 156
Efferocytosis in the tumor microenvironment
Werfel, T. A., & Cook, R. S. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0698-5 · Cited by 156
Sterile Inflammatory Response in Acute Pancreatitis
Hoque, R., Malik, A. F., Gorelick, F. S., & Mehal, W. Z. (2012) · Pancreas · doi:10.1097/mpa.0b013e3182321500 · Cited by 145
Metadata
- Authors
- Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., Espevik, T., Lien, E., Fitzgerald, K. A., Rock, K. L., Moore, K. J., Wright, S. D., Hornung, V., & Latz, E.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Harvard University (US)
- Michigan State University (US)
- University of Michigan (US)
- Ludwig-Maximilians-Universität München (DE)
- Norwegian University of Science and Technology (NO)
- CSL (Australia) (AU)
- University of Bonn (DE)
- Corresponding author
- Latz, Eicke
- ORCID
- Venue
- Nature
- Published
- 2010-04-01
- Volume
- 464
- Issue
- 7293
- Pages
- 1357-1361
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2946640
- OpenAlex
- W1972483153
- Cited by
- 4,026
- References
- 31
- Citations by year
- 2026: 274 · 2025: 255 · 2024: 291 · 2023: 299 · 2022: 321 · 2021: 307 · 2020: 291 · 2019: 270 · 2018: 282 · 2017: 245 · 2016: 199 · 2015: 228 · 2014: 194 · 2013: 197 · 2012: 197
- FWCI
- 72.42
- Type
- journal article
- Language
- en
- Update notices
- erratum (2010-07-29)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship@UMassChan (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL093262)
- National Institute of Allergy and Infectious Diseases (R01AI075318, R01AI083713)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- NLRP3 inflammasome, cholesterol crystals, atherogenesis, atherosclerosis, phagocytes, IL-1β, IL-1α, cathepsin B, cathepsin L, ASC, caspase-1, LDL receptor, apolipoprotein E deficiency, high-cholesterol diet
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Carrier Proteins, Cathepsin B, Cholesterol, Crystallization, Cytoskeletal Proteins, Diet, Atherogenic, Female, Humans, Inflammation, Interleukin-1, Lysosomes, Mice, Inbred C57BL, Peritoneal Cavity, Phagocytes, Receptors, LDL, Time Factors, Bone Marrow Transplantation, Interleukin-18, Atherosclerosis, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Cathepsin L
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
